Borzio M, Caldara R, Borzio F, Piepoli V, Rampini P, Ferrari C
Gut. 1983 Jul;24(7):631-6. doi: 10.1136/gut.24.7.631.
To further evaluate thyroid function in patients with liver disease, we have measured total and free T3 and T4, thyroxine binding globulin, basal and thyrotropin releasing hormone-stimulated thyrotropin and thyroglobulin antibodies in 33 patients with liver cirrhosis, in 22 with chronic hepatitis and in 30 healthy controls. All the patients but one were clinically euthyroid. T3, FT3, T3/thyroxine binding globulin and T4/thyroxine binding globulin ratios and thyrotropin after thyrotropin releasing hormone were significantly reduced, while FT4, thyroxine binding globulin and thyrotropin were significantly increased in liver cirrhosis. In chronic hepatitis group, FT3 and T3/thyroxine binding globulin ratio were significantly lower and thyroxine binding globulin and FT4 were higher than in healthy controls. The between patients comparison revealed a significantly lower T3, FT3, T3/thyroxine binding globulin and T4/thyroxine binding globulin ratios and delta thyrotropin in cirrhotics. Thyroglobulin antibodies were present at high titre only in two patients one of whom having evidence of Hashimoto's thyroiditis with subclinical hypothyroidism. The correlation coefficient between T4/thyroxine binding globulin ratio and FT4 were lower in patients than in controls. Furthermore an abnormal thyrotropin response to thyrotropin releasing hormone was shown in 10 cirrhotics and in four patients with chronic hepatitis. Serum T3 significantly correlated with serum bilirubin, albumin, and prothrombin time in both groups of patients. The present data confirm the existence of several abnormalities of thyroid function tests in patients with chronic liver disease, although showing that euthyroidism is almost always maintained, probably as a result of low-normal FT3 and high-normal FT4. Furthermore, T3 serum levels appear to parallel the severity of liver dysfunction.
为进一步评估肝病患者的甲状腺功能,我们检测了33例肝硬化患者、22例慢性肝炎患者及30名健康对照者的总T3、游离T3、总T4、游离T4、甲状腺素结合球蛋白、基础促甲状腺素及促甲状腺素释放激素刺激后的促甲状腺素,以及甲状腺球蛋白抗体。除1例患者外,所有患者临床甲状腺功能均正常。肝硬化患者的T3、游离T3、T3/甲状腺素结合球蛋白及T4/甲状腺素结合球蛋白比值以及促甲状腺素释放激素刺激后的促甲状腺素显著降低,而游离T4、甲状腺素结合球蛋白及促甲状腺素显著升高。在慢性肝炎组中,游离T3及T3/甲状腺素结合球蛋白比值显著低于健康对照者,而甲状腺素结合球蛋白及游离T4则高于健康对照者。患者之间的比较显示,肝硬化患者的T3、游离T3、T3/甲状腺素结合球蛋白及T4/甲状腺素结合球蛋白比值以及促甲状腺素变化值显著降低。仅2例患者甲状腺球蛋白抗体呈高滴度,其中1例有桥本甲状腺炎伴亚临床甲状腺功能减退的证据。患者中T4/甲状腺素结合球蛋白比值与游离T4之间的相关系数低于对照者。此外,10例肝硬化患者及4例慢性肝炎患者促甲状腺素对促甲状腺素释放激素的反应异常。两组患者血清T3均与血清胆红素、白蛋白及凝血酶原时间显著相关。目前的数据证实慢性肝病患者存在多种甲状腺功能检查异常,尽管表明几乎总能维持甲状腺功能正常,这可能是由于游离T3略低于正常及游离T4略高于正常所致。此外,血清T3水平似乎与肝功能障碍的严重程度平行。